Publications by authors named "Jill Slack-Davis"

Claim this Profile
D
Dichotomous ovarian cancer-initiating potential of Pax8+ cells revealed by a mouse genetic mosaic model.
Jianhao Zeng, Astrid Catalina Alvarez-Yela, Eli Casarez, Ying Jiang, Lixin Wang, Jill K Slack-Davis

iScience· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer model.
Jessica C Price, Elham Azizi, L A Naiche, Jenny G Parvani, Priyanka Shukla, Jill K Slack-Davis

PLoS One· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer.
Siva Sai Krishna Dasa, Galina Diakova, Ryo Suzuki, Anne M Mills, Michael F Gutknecht, Jill K Slack-Davis

Theranostics· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).
Jennifer M Scalici, Sanja Arapovic, Erin J Saks, Kristen A Atkins, Gina Petroni, Jill K Slack-Davis

Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3.
Evan P Taddeo, Stefan R Hargett, Sujoy Lahiri, Marin E Nelson, Jason A Liao, Jill K Slack-Davis

Sci Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.
Marin E Nelson, Sujoy Lahiri, Jenny D Y Chow, Frances L Byrne, Stefan R Hargett, Jill K Slack-Davis

Nat Commun· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival.
Jennifer S Winn, Mary G Baker, Ibrahim S Fanous, Jill K Slack-Davis, Kristen A Atkins

Oncology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.
Barbara Dziegielewska, Eli V Casarez, Wesley Z Yang, Lloyd S Gray, Jaroslaw Dziegielewski, Jill K Slack-Davis

Mol Cancer Ther· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased peritoneal ovarian cancer growth in mice lacking expression of lipid phosphate phosphohydrolase 1.
John Nakayama, Timothy A Raines, Kevin R Lynch, Jill K Slack-Davis

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women at extreme risk for obesity-related carcinogenesis: Baseline endometrial pathology and impact of bariatric surgery on weight, metabolic profiles and quality of life.
Susan C Modesitt, Peter T Hallowell, Jill K Slack-Davis, Ryan D Michalek, Kristen A Atkins

Gynecol Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VCAM-1 on peritoneum and α4β1 integrin in endometrium and their implications in endometriosis.
Amy K Schutt, Kristen A Atkins, Jill K Slack-Davis, Dale W Stovall

Int J Gynecol Pathol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic vulnerabilities in endometrial cancer.
Frances L Byrne, Ivan K H Poon, Susan C Modesitt, Jose L Tomsig, Jenny D Y Chow, Jill K Slack-Davis

Cancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin.
Jennifer M Scalici, Christine Harrer, Anne Allen, Amir Jazaeri, Kristen A Atkins, Jill K Slack-Davis

Gynecol Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancer.
Jennifer M Scalici, Stephanie Thomas, Christine Harrer, Timothy A Raines, Joanna Curran, Jill K Slack-Davis

J Nucl Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.
Jayme B Stokes, Sara J Adair, Jill K Slack-Davis, Dustin M Walters, Robert W Tilghman

Mol Cancer Ther· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix rigidity regulates cancer cell growth and cellular phenotype.
Robert W Tilghman, Catharine R Cowan, Justin D Mih, Yulia Koryakina, Daniel Gioeli, Jill K Slack-Davis

PLoS One· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1 and Src: antagonistic regulators of tumor growth and metastasis.
Jill Slack-Davis, John O Dasilva, Sarah J Parsons

Cancer Cell· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The promise of antiangiogenic therapy for ovarian cancer.
Amir A Jazaeri, Jill K Slack-Davis

Cancer Biol Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model.
Jill K Slack-Davis, E Daniel Hershey, Dan Theodorescu, Henry F Frierson, J Thomas Parsons

Mol Cancer Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis.
Jill K Slack-Davis, Kristen A Atkins, Christine Harrer, E Daniel Hershey, Mark Conaway

Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention.
J Thomas Parsons, Jill Slack-Davis, Robert Tilghman, W Gregory Roberts

Clin Cancer Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular characterization of a novel focal adhesion kinase inhibitor.
Jill K Slack-Davis, Karen H Martin, Robert W Tilghman, Marcin Iwanicki, Ethan J Ung

J Biol Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells.
Robert W Tilghman, Jill K Slack-Davis, Natalia Sergina, Karen H Martin, Marcin Iwanicki

J Cell Sci· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion.
Scott T Eblen, Jill K Slack-Davis, Adel Tarcsafalvi, J Thomas Parsons, Michael J Weber

Mol Cell Biol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging views of integrin signaling: implications for prostate cancer.
Jill K Slack-Davis, J Thomas Parsons

J Cell Biochem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis